NIAID Banner Logo Image

Mycobacterium Citations List: January, 2019

Literature Citations

1. Facile Synthesis of 1,4-Benzodiazepine-2,5-diones and Quinazolinones from Amino acids as Anti-tubercular Agents. Anil, S., R. Shobith, K.R. Kiran, T.R. Swaroop, N. Mallesha, and M.P. Sadashiva. New Journal of Chemistry, 2019. 43(1): p. 182-187. ISI[000454329100022].
[WOS]. TB_01_2019.

2. α-Sulfonamidophosphonates as New Anti-mycobacterial Chemotypes: Design, Development of Synthetic Methodology, and Biological Evaluation. Bhagat, S., M. Supriya, S. Pathak, D. Sriram, and A.K. Chakraborti. Bioorganic Chemistry, 2019. 82: p. 246-252. PMID[30391855].
[PubMed]. TB_01_2019.

3. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex. Brown-Elliott, B.A. and R.J. Wallace, Jr. Antimicrobial Agents and Chemotherapy, 2019. 63(2). e01919-18. PMID[30509936]. PMCID[PMC6355601].
[PubMed]. TB_01_2019.

4. Design, Synthesis and Antitubercular Activity of 4-Alkoxy-triazoloquinolones Able to Inhibit the M. tuberculosis DNA Gyrase. Carta, A., A. Bua, P. Corona, S. Piras, I. Briguglio, P. Molicotti, S. Zanetti, E. Laurini, S. Aulic, M. Fermeglia, and S. Pricl. European Journal of Medicinal Chemistry, 2019. 161: p. 399-415. PMID[30384044].
[PubMed]. TB_01_2019.

5. Design, Synthesis, and Evaluation of Tetraethylene glycol Tethered Ciprofloxacin-Isatin Hybrids as Novel Antitubercular Agents. Gao, T., W. Hu, Z. Zeng, S. Sun, and R. Wang. Journal of Heterocyclic Chemistry, 2019. 56(1): p. 306-311. ISI[000455256500034].
[WOS]. TB_01_2019.

6. High-dose Nitric oxide as a Potential New Therapeutic Agent against Mycobacterium abscessus. Ghaffari, A., J.L. da Silva, K. Bogdanovski, A.M. Zelazny, and K.N. Olivier. European Respiratory Journal, 2018. 52. PA5463. ISI[000455567107211].
[WOS]. TB_01_2019.

7. Easy-to-synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis. Guardia, A., J. Baiget, M. Cacho, A. Perez, M. Ortega-Guerra, W. Nxumalo, S. Khanye, J. Rullas, F. Ortega, E. Jimenez, E. Perez-Herran, M.T. Fraile-Gabaldon, J. Esquivias, R. Fernandez, E. Porras-De Francisco, L. Encinas, M. Alonso, I. Giordano, C. Rivero, J. Miguel-Siles, J. Osende, K. Badiola, P.J. Rutledge, M.H. Todd, M. Remuinan, and C. Alemparte. Journal of Medicinal Chemistry, 2018. 61(24): p. 11327-11340. PMID[30457865].
[PubMed]. TB_01_2019.

8. Design, Synthesis, and in Vitro Anti-mycobacterial Activities of Propylene Tethered Benzofuran-Isatin Hybrids. Guo, H. Journal of Heterocyclic Chemistry, 2019. 56(1): p. 338-342. ISI[000455256500039].
[WOS]. TB_01_2019.

9. In Vitro Evaluation of Dinactin, a Potent Microbial Metabolite against Mycobacterium tuberculosis. Hussain, A., M.A. Rather, Z.S. Bhat, A. Majeed, M. Maqbool, A.M. Shah, M.A. Aga, A. Shah, S. Mushtaq, P.L. Sangwan, Q.P. Hassan, and Z. Ahmad. International Journal of Antimicrobial Agents, 2019. 53(1): p. 49-53. PMID[30267759].
[PubMed]. TB_01_2019.

10. Acridine-based (Thio)semicarbazones and Hydrazones: Synthesis, in Vitro Urease Inhibition, Molecular Docking and in-Silico ADME Evaluation. Isaac, I.O., M. Al-Rashida, S.U. Rahman, R.D. Alharthy, A. Asari, A. Hameed, K.M. Khan, and J. Iqbal. Bioorganic Chemistry, 2019. 82: p. 6-16. PMID[30267972].
[PubMed]. TB_01_2019.

11. Design, Synthesis and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity. Jarrad, A.M., C.W. Ang, A. Debnath, H.J. Hahn, K. Woods, L. Tan, M.L. Sykes, A.J. Jones, R. Pelingon, M.S. Butler, V.M. Avery, N.P. West, T. Karoli, M.A.T. Blaskovich, and M.A. Cooper. Journal of Medicinal Chemistry, 2018. 61(24): p. 11349-11371. PMID[30468386]. PMCID[PMC6311682].
[PubMed]. TB_01_2019.

12. Synthesis and in Vitro Characterization of Trehalose-based Inhibitors of Mycobacterial Trehalose 6-phosphate phosphatases. Kapil, S., C. Petit, V.N. Drago, D.R. Ronning, and S.J. Sucheck. ChemBioChem, 2019. 20(2): p. 260-269. PMID[30402996].
[PubMed]. TB_01_2019.

13. Design, Synthesis, and Evaluation of Novel Diphenyl ether Derivatives against Drug-susceptible and Drug-resistant Strains of Mycobacterium tuberculosis. Kar, S.S., V.G. Bhat, V.P. Shenoy, I. Bairy, and G.G. Shenoy. Chemical Biology & Drug Design, 2019. 93(1): p. 60-66. PMID[30118192].
[PubMed]. TB_01_2019.

14. Design, Synthesis and Molecular Docking Studies of Novel Triazole-chromene Conjugates as Antitubercular, Antioxidant and Antifungal Agents. Khare, S.P., T.R. Deshmukh, J.N. Sangshetti, V.S. Krishna, D. Sriram, V.M. Khedkar, and B.B. Shingate. ChemistrySelect, 2018. 3(46): p. 13113-13122. ISI[000453576900021].
[WOS]. TB_01_2019.

15. Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Conjugated Quinazoline-sulfonamide Scaffold. Kumar, A.S., J. Kudva, B.R. Bharath, V.M. Rai, M. Kumar, V. Kumar, and S.P. Sajankila. ChemistrySelect, 2018. 3(48): p. 13586-13595. ISI[000454534500005].
[WOS]. TB_01_2019.

16. Synthesis and Evaluation of α-Aminoacyl amides as Antitubercular Agents Effective on Drug Resistant Tuberculosis. Makane, V.B., V.S. Krishna, E.V. Krishna, M. Shukla, B. Mahizhaveni, S. Misra, S. Chopra, D. Sriram, V.N.A. Dusthackeer, and H.B. Rode. European Journal of Medicinal Chemistry, 2019. 164: p. 665-677. PMID[30654238].
[PubMed]. TB_01_2019.

17. Synthesis and Evaluation of Novel Substituted 1,2,3-Triazolyldihydroquinolines as Promising Antitubercular Agents. Marvadi, S.K., V.S. Krishna, D. Sriram, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2019. 29(4): p. 529-533. PMID[30638877].
[PubMed]. TB_01_2019.

18. A High-throughput Whole Cell Screen to Identify Inhibitors of Mycobacterium tuberculosis. Ollinger, J., A. Kumar, D.M. Roberts, M.A. Bailey, A. Casey, and T. Parish. Plos One, 2019. 14(1). e0205479. PMID[30650074]. PMCID[PMC6334966].
[PubMed]. TB_01_2019.

19. Synthesis, in Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents. Pitucha, M., Z. Karczmarzyk, M. Swatko-Ossor, W. Wysocki, M. Wos, K. Chudzik, G. Ginalska, and A. Fruzinski. Molecules, 2019. 24(2). E251. PMID[30641902]. PMCID[PMC6359303].
[PubMed]. TB_01_2019.

20. In Vitro Inhibition Potential of mono-N-Octyl phthalate on Mycobacterium tuberculosis H37Ra: Possibility of Binding to Mycobacterial PknB-An in Silico Approach. Rajiniraja, M., A. Sivaramakrishna, V. Sabareesh, and G. Jayaraman. Biotechnology and Applied Biochemistry, 2018. 65(6): p. 865-875. PMID[30086194].
[PubMed]. TB_01_2019.

21. Design, Synthesis, and Bioevaluation of a Novel Class of (E)-4-Oxo-crotonamide Derivatives as Potent Antituberculosis Agents. Ren, J., J. Xu, G. Zhang, C. Xu, L. Zhao, X. You, Y. Wang, Y. Lu, L. Yu, and J. Wang. Bioorganic & Medicinal Chemistry Letters, 2019. 29(4): p. 539-543. PMID[30630715].
[PubMed]. TB_01_2019.

22. Biological Activities of Various Extracts from Salvia cassia Sam. ex Rech.f. And Chemical Composition of Its Most Active Extract. Şen, B., B. Gurda, M. Bilgin, D. Satana, B. Demirci, N. Tan, and A. Mat. Records of Natural Products, 2019. 13(1): p. 24-36. ISI[000455644400004].
[WOS]. TB_01_2019.

23. Design, Synthesis and Biological Screening of Novel 1,3,4-Oxadiazoles as Antitubercular Agents. Tambe, M.S., A. Choudhari, D. Sarkar, J. Sangshetti, R. Patil, and S.S. Gholap. ChemistrySelect, 2018. 3(47): p. 13304-13310. ISI[000453917200001].
[WOS]. TB_01_2019.

24. Synthesis and Biological Evaluation of 1H-Pyrrolo[2,3-d]pyrimidine-1,2,3-triazole Derivatives as Novel Anti-tubercular Agents. Shiva Raju, K., S. AnkiReddy, G. Sabitha, V. Siva Krishna, D. Sriram, K. Bharathi Reddy, and S. Rao Sagurthi. Bioorganic & Medicinal Chemistry Letters, 2019. 29(2): p. 284-290. PMID[30497913].
[PubMed]. TB_01_2019.

25. Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their in Vitro Efficacy against Mycobacterium tuberculosis. van Zyl, L., J.M. Viljoen, R.K. Haynes, M. Aucamp, A.H. Ngwane, and J. du Plessis. AAPS PharmSciTech, 2019. 20(1): p. 33. PMID[30604176].
[PubMed]. TB_01_2019.

26. Inhalable Liposomes of Glycyrrhiza glabra Extract for Use in Tuberculosis: Formulation, in Vitro Characterization, in Vivo Lung Deposition, and in Vivo Pharmacodynamic Studies. Viswanathan, V., R. Pharande, A. Bannalikar, P. Gupta, U. Gupta, and A. Mukne. Drug Development and Industrial Pharmacy, 2019. 45(1): p. 11-20. PMID[30122088].
[PubMed]. TB_01_2019.

27. Design, Synthesis, and Antimycobacterial Activities of Diethylene glycol Tethered Moxifloxacin-Isatin Hybrids. Xu, Z., S. Zhao, J. Deng, Q. Wang, and Z. Lv. Journal of Heterocyclic Chemistry, 2019. 56(1): p. 325-330. ISI[000455256500037].
[WOS]. TB_01_2019.

28. Gatifloxacin-Isatin Hybrids and Their Antimycobacterial Activities. Xu, Z., S. Zhao, J. Deng, Q. Wang, and Z. Lv. Journal of Heterocyclic Chemistry, 2019. 56(1): p. 331-337. ISI[000455256500038].
[WOS]. TB_01_2019.

29. Ciprofloxacin-Isatin Hybrids and Their Antimycobacterial Activities. Xu, Z., S. Zhao, J. Deng, Q. Wang, and Z. Lv. Journal of Heterocyclic Chemistry, 2019. 56(1): p. 319-324. ISI[000455256500036].
[WOS]. TB_01_2019.

Patent Citations

30. Preparation of Sequanamycin Macrolides Useful in the Treatment of Tuberculosis. Benedetti, Y., F. Halley, and J. Zhang. Patent. 2019. 2018-EP70342 2019020767: 64pp.
[Patent]. TB_01_2019.

31. Preparation of Sequanamycin Macrolides Useful in the Treatment of Tuberculosis. Benedetti, Y., F. Halley, and J. Zhang. Patent. 2019. 2018-EP70331 2019020759: 60pp.
[Patent]. TB_01_2019.

32. Preparation of Sequanamycin Macrolides Useful in the Treatment of Tuberculosis. Benedetti, Y., J. Zhang, and F. Halley. Patent. 2019. 2018-EP70337 2019020763: 71pp.
[Patent]. TB_01_2019.

33. Novel Alkenyl and Beta-substituted Phosphonates as Antimicrobial Agents. Dowd, C., X. Wang, R.C. Brothers, A.R.O. John, R. Edwards, M. Meyers, S. Arnett, R. Couch, and K. Heidel. Patent. 2019. 2018-US39777 2019005982: 74pp.
[Patent]. TB_01_2019.

34. Preparation of Substituted Pyrimidin-2(1H)-ones as Antimicrobial Agents. Reddy, H.R.K., P.R. Sebahar, and R.E. Looper. Patent. 2019. 2017-US41793 2019013790: 95pp.
[Patent]. TB_01_2019.

35. Preparation of Substituted N-(2-Oxo-1,2-dihydropyrimidin-4-yl)Benzamides as Antimicrobial Agents.Reddy, H.R.K., P.R. Sebahar, C.M. Serrano, and R.E. Looper. Patent. 2019. 2017-US41790 2019013789: 117pp.
[Patent]. TB_01_2019.

36. Activity of Gold-complexed Compounds against Mycobacterium tuberculosis and Mycobacterium abscessus Infections. Rohde, K.H. and O. Munro. Patent. 2019. 2018-US39608 2019005876: 73pp.
[Patent]. TB_01_2019.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019